On various stroke models, transgenic animals lacking T cells, or animals with antibody-mediated depletion of CD4+, CD8+, or γδT cells presented ischemic damage reduction compared to corresponding WT [199,200,201,202]. The gene discussed is CD4; the disease is Stroke.